Tech in Pharma – Report Bundle (7 Reports)

Tech in Pharma Industry Bundle Report Overview

Although the pharmaceutical industry had been slow to adopt technological innovations, the onset of COVID-19 has dramatically altered the situation. The latest technologies, Augmented Reality (AR), Big Data, and Artificial Intelligence (AI), among others, will assist pharmaceutical companies in speeding up the research and development process, creating personalized products, and conducting testing in novel ways. Finally, these technologies will improve healthcare effectiveness and efficiency thereby transforming the patient and provider experience.

Explore actionable market insights from the following data in our ‘Tech in Pharma’ bundle:

• Key industry trends and the impact of the latest technologies (AI, Big Data, AR, IoT) on the pharmaceutical industry, and how these, in turn, can improve and transform patient and provider experience.
• Detailed analysis of industry participants across various stages of the value chain.
• Growth opportunities for drug discovery and development will help make strategic decisions to improve the clinical trial design.
• Technology companies can analyze their current position in the value chain and how well they can serve their target markets or make a move to capture more market share.
• Key stakeholders across various stages of the value chain for competitor evaluation and an overview of the industry participants.
• Market growth and forecast information, along with alternate data capabilities offered within these reports, especially on deals.

The ‘Tech in Pharma’ bundle is a cost-effective solution as it provides access to multiple reports at a discounted price, compared to buying individual reports:

• Artificial Intelligence (AI) in Drug Discovery (Single user price: $995)
• Big Data in Pharmaceuticals (Single user price: $995)
• Digital Health in Immunology (Single user price: $995)
• Digital Health in Neurology (Single user price: $995)
• Internet of Things (IoT) in Healthcare (Single user price: $995)
• Smart Pharma (Single user price: $995)
• Virtual Clinical Trials (Single user price: $995)

Click here to download sample pages of every report included in the Tech in Pharma bundle

By purchasing the bundle worth $6,965 you can get access to a wealth of information and insights:

• In-Depth Insights on Market and Trends – The report helps to understand the key sector trends across the 7 reports including technology, regulatory and macroeconomic factors impacting the healthcare industry.
• Value Chain Analysis for Respective Themes – The reports provide extensive value chain analysis for the pharma, healthcare, and medical devices sectors, based on the impact of new-age technological innovations. This will aid the industry participants across all stages to analyze their position and identify potential growth or investment opportunities.
• Case Studies – The reports offer several case studies highlighting the activity of leading players in the space, the ways in which pharma companies are using new-age technology, and collaborations between pharma and specialist technology vendors in pharma
• Competitive Landscape – It provides a list of leading companies and their competitive positions in the Tech in Pharma theme.
• GD Proprietary Scorecard – The sector scorecards will help target companies to determine which companies are best positioned for a future filled with disruptive threats.

We recommend this valuable source of information to anyone involved in:

• Pharma/Medical Device Companies
• Clinical Research Organizations (CROs)
• Contract Manufacturers and CDMOs
• Consulting Companies
• Academia
• Technology Companies/Start-ups
• Consultants
• PE/VC Firms/Investment Banks

Click here to download consolidated sample pages of reports in the Tech in Pharma bundle

Report 1 – Thematic Research: Artificial Intelligence in Drug Discovery

There has been an increase in interest in the use of AI in drug discovery during the last few years, as witnessed by the emergence of an ever-increasing number of start-ups in this field, an increase in the number of drug discovery partnerships, and record levels of investment. AI will be a key driver of healthcare innovation in the future through a variety of applications such as chronic disease management, drug discovery and development, clinical trial improvement, manufacturing, and supply chain management. COVID-19 is also one of the major reasons for the rapid innovation and investment in AI.

AI in Drug Discovery Value Chain Analysis

For more insights on artificial intelligence in drug discovery, download a free report sample

Report 2 – Thematic Research: Big Data in Pharma

The data and analytics market in the pharma sector was worth $1.4 billion in 2020. Big data platforms, business intelligence and data discovery tools, and data and content management are the three technology segments in the data and analytics market. Big data analytics serve as the engine for emerging technologies like artificial intelligence (AI), Internet of Things (IoT), 5G, and cloud. There are numerous use cases for big data analytics in the pharma sector, including drug discovery and development acceleration, manufacturing process optimization, supply chain management, and the development of innovative sales and marketing strategies.

Big Data Value Chain in Pharma

For more insights on big data in the pharma industry, download a free report sample

Report 3 – Thematic Research: Digital Health in Immunology

In healthcare, digital technologies are constantly evolving and finding new applications. The COVID-19 pandemic has also accelerated digital health innovation as patients and physicians look for alternatives to in-person care. Tools like digital therapeutics (DTx), mobile health (mHealth), wearable technology, digital biomarkers, telemedicine, virtual reality (VR), and augmented reality (AR) can be used to track health, deliver therapeutic interventions, and contribute to research. Digital health technologies also have the potential to improve disease treatment and management for patients while also being personalized for everyone. Furthermore, digital health tools have become increasingly focused on specific indications, such as immunology, where numerous healthtech companies are vying for market share.

Digital Health in Immunology Value Chain Analysis

For more insights on digital health in immunology, download a free report sample

Report 4 – Thematic Research: Digital Health in Neurology

The COVID-19 pandemic has accelerated digital health innovation. HCPs have been quick to implement alternative solutions to in-person care to ensure patients have access to diagnostic as well as therapeutic services. In the coming days, recruiting top digital talent will be a priority across IoT and connected devices and is going to be an essential tool in the validation and utilization of digital health technologies in the neurology space. Once the clinical evidence for digital health interventions in patients with specific conditions begins to expand, the capabilities of the technologies will become more specific and will go on to influence guidance and regulations for direct-to-consumer products in the neurology and mental health space.

Leading Players in the Neurology Digital Health Space

To know more about digital health in neurology, download a free report sample

Report 5 – Thematic Research: Internet of Things in Healthcare

IoT is a critical component of digitalization in the healthcare industry. The COVID-19 pandemic has accelerated the use of IoT technologies in the pharmaceutical industry, such as virtual trials. Robotics is also used extensively in the pharmaceutical and medical device industries. Smart robots are being used in drug development for high throughput screening of drug candidates, and they have a lot of potential in manufacturing, supply chain, and distribution. IoT also assists in the inspection of finished goods, packaging, and supply chain to adhere to quality requirements.

Report 6 – Thematic Research: Smart Pharma

The COVID 19 pandemic has provided businesses with an unprecedented opportunity to accelerate and implement technology-driven changes to the way they operate, even if those changes had already begun prior to the pandemic. More organizations are looking for ways to embrace emerging technologies to remain competitive, as technological adoption brings a wide range of benefits, such as improved operational efficiency and increased customer engagement. Innovative technologies enable the pharmaceutical industry to increase efficiency, develop agile operational models, and innovate processes throughout the value chain. Companies that adopt smart technologies faster will be in a better position to gain a competitive advantage and reduce financial risks.

Number of AI Drug Discovery Partnerships with Big Pharma

For more insights on smart pharma, download a free report sample

Report 7 – Thematic Research: Virtual Clinical Trials

COVID-19 lockdowns and social distancing measures hampered clinical trials and accelerated the use of virtual trials. Virtual trials are expected to play an important role in patient-centric research by improving convenience and experience with the use of technology and digital tools. Most real-world data (RWD) generated by digital devices in virtual trials will aid in enhancing the drug development process in the future. Furthermore, it can be used to improve trial design, eligibility criteria, and trial access, as well as provide deeper patient insights. Many companies in the virtual trials space offer their patient-facing services on customizable and compliant app-based platforms for their clients and assures that the patient experience is convenient, seamless, and secure.

Virtual Clinical Trials Value Chain

For more insights on virtual clinical trials, download a free report sample